DISEASE SCANNER
Global Incurable Diseases Tracker
Pulmonary Hypertension (PAH)
A rare but serious condition characterized by high blood pressure in the pulmonary arteries, leading to right heart failure. Group 1 PAH is a progressive disease affecting the small pulmonary arteries, causing vessel narrowing and increased resistance to blood flow.
1.0M
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Echocardiogram
- 2Right heart catheterization (gold standard)
- 3Pulmonary function tests
- 4CT pulmonary angiography
- 5V/Q scan
- 6Blood tests (BMP, autoimmune markers)
- 76-minute walk test
Prognosis
Improved with modern therapy; median survival 7-10 years. Without treatment, median survival 2.8 years. Prognosis depends on functional class and hemodynamics at diagnosis.
Prevention
- No primary prevention
- Genetic counseling for familial cases
- Avoid anorexigen drugs
- Early recognition and treatment of underlying causes
Research Status
Multiple targeted therapies (prostacyclins, endothelin receptor antagonists, PDE-5 inhibitors) improve symptoms and survival. Lung transplantation for advanced disease. Early diagnosis critical.
Affected Countries
Sources
- https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-hypertension
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.